Atrium Therapeutics
RNA
#4568
Rank
ยฃ1.83 B
Marketcap
ยฃ11.64
Share price
-6.47%
Change (1 day)
-55.01%
Change (1 year)

Revenue for Atrium Therapeutics (RNA)

Revenue in 2026 (TTM): ยฃ19.05 Million

According to Atrium Therapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ18.83 Million. In 2025 the company made a revenue of ยฃ14 Million an increase over the revenue in the year 2024 that were of ยฃ8.19 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Atrium Therapeutics from 2023 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) ยฃ19.05 M36.02%
2025 ยฃ14 M70.85%
2024 ยฃ8.19 M11.6%
2023ยฃ7.34 M